GOLD SPONSORS
CONTENT SPONSORS
CONTENT SPONSORS
SUPPORTED BY
High dimensional data analysis – applications in drug discovery and clinical trials
Yann Abraham, Senior Principal Scientist, Janssen
Digitization of AstraZeneca Labs
Amrik Mahal, Global Head, IT for Research, AstraZeneca
Robin Brouwer, IT lead for Global Labs, Early Science, AstraZeneca
Application of state of the art data and digital technologies to develop, supply and launch innovative medicines
Vijay Raju, VP, Global Head of Analytical R&D, Novartis
Digitalization in the Clinical Laboratory
Mathew Divine, Head of Digital Lab in Clinical Development & Operations, Boehringer Ingelheim
The application of AI/ML to drive innovation in lab
Djork-Arné Clevert, Head of Machine Learning Research, Bayer
Turning Data into Decisions
Laura Williams, Decision Science Manager, GSK
Generating FAIR Lab data at AbbVie
Rainer Winnenburg, Team Lead Literature-based Scientific Discovery – FAIR Data, AbbVie
Regulatory Document Automation
Pamela Sepulveda, Director, Digital Strategy, Pfizer
Justin Kenagy, Director, Digital Business Operations, Pfizer
The Pistoia Alliance Unified Integrated Knowledge Base (UIKB) – creating a community-led knowledge base for R&D Application, Instrument, Data, and Services Integrations
Anca Ciobanu, Lab of the Future Lead, Pistoia Alliance
Giving time back to Science with provision scientific services
Richard Snell, Director, Scientific Services EMEA, GSK
Data Assets driving sustainable business transformation in labs
Ralph Häfeli, Head Strategic Business Partnering, Technical R&D, Novartis
Collaborative Drug Design In Virtual Reality At UCB
Sasker Grootjans, New Medicines IT Sr. Project Manager, UCB
Technologies to support oligonucleotide/new modality alignment in early science
Phil Williams, Programme Manager, Early Science, R&D IT, AstraZeneca
Revolutionising Experiment Data Capture For Data Re-Use & Analytics
Penny Smee, Director & Senior Product Owner, GSK
Bringing Machine Learning in operations for drug discovery: the example of compound property predictors
Christophe Chabbert, Senior Scientist & Product Manager, Roche
The design and operational rollout of a connected health analytics platform
Oliver Meier, Head Strategy, Design and Operations, Connected Health, Novartis
Using robotics and automation to invent, improve and design concepts in order to reduce human interventions and remove repetitive work
James Love, Director, Applied Automation, Novo Nordisk
Lab Automation – Delivering solutions and Future directions
Philip Hopcroft, Associate Principal Scientist, AstraZeneca
The Lab of the Future at Roche Pharma – creating a physical infrastructure that supports scientific innovation
Geo Adam, Global Head of pRED Facilities & Infrastructure Projects, Roche
Business strategy and capability delivery for the Lab of the Future at Takeda Pharmaceuticals
Christoph Pistek, Head, Innovation & Technology Sciences, R&D, Takeda Pharmaceuticals
Creating space for innovation at CSL Behring
Vicky Pirzas, VP, Recombinant Product Development, CSL Behring
Cancer Research Horizons – Driving innovations in cancer drug discovery through collaborative alliances with industry and academia
Jennifer McKelvie, Head of Portfolio and Data Operations, Cancer Research Horizons (CRUK)
The Good, the Bad and the Ugly: the three faces of digital collaboration in drug design
Fabio Rancati Lead Optimization Unit Head , Chiesi Farmaceutici
The path towards a modern research laboratory – tales from the trenches
Brian Gilman, VP Research Technology, Vertex
Strategic Procurement in support of the Scientist: The Roche journey towards a Progressive Procurement value chain
Francesca Nani, Sr. Market Solutions Manager – R&D Solutions, Roche
The Lab of the Future at Seagen– continuation of a transformative journey
Mark McCord-Amasis, Vice President, Real Estate & Facilities, Seagen
Accelerating decision making through parallel medicinal chemistry
Francesco Rianjongdee, Scientific Leader, GSK